Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Patient-specific Predictors of Haemolysis with Percutaneous Ventricular Assist Devices
Author(s): Alexander E Sullivan , Hannah Granger , Leonie Dupuis , et al Added: 1 year ago

Prevention & Chronic Conditions

Heart Failure
Device-Based Strategies for Guideline-Directed Therapy in Heart Failure
Author(s): Renzo Laborante , Attilio Restivo , Daniela Mele , et al Added: 1 year ago

Prevention & Chronic Conditions

Heart Failure
HFSA 25: The INTEGRA-D Trial
Author(s): Nir Uriel Added: 7 months ago
HFSA 25 - CCM-D was associated with successful defibrillation and symptom improvement in patients with HFrEF at 6 months in the INTEGRA-D Trial.Dr Nir Uriel (NewYork-Presbyterian, Columbia University Irving Medical Center, US) joins us to discuss findings from the Integra-D trial, evaluating a novel implantable device that provides both cardiac contractility modulation and defibrillation… View more

Heart Failure
Advancing Heart Failure Care: Timely Referral and Life‑prolonging Strategies with HeartMate 3 Left Ventricular Assist Device
Author(s): Sanjeev Gulati Added: 6 months ago

Heart Failure
Pre-implant Right Ventricular dP/dt Can Predict Severe Right Ventricular Failure After Left Ventricular Assist Device Implantation
Author(s): Parth Visrodia , Aniket S Rali , Gabriel Hernandez , et al Added: 7 months ago

Imaging & Diagnostics

Heart Failure
Iron Deficiency in LVAD Patients
Author(s): William Herrik Nielsen , Finn Gustafsson Added: 1 year ago

Heart Failure
HFA 24: The RELIEVE-HF Trial: Differential Effects of V-Wave Device
Author(s): Michael R Zile Added: 2 years ago
HFA 24 - We are joined onsite by Dr Michael Zile (Medical University of South Carolina, US) to discuss the outcomes of the RELIEVE-HF trial.RELIEVE-HF is designed to evaluate the safety and effectiveness of the V-Wave interatrial shunt system in patients with heart failure. 605 participants with New York Heart Association (NYHA) functional class II, class III or class IV heart failure, who had… View more

Heart Failure
ACC 26: STEMI-DTU Trial – Primary Unloading and Delayed Reperfusion
Author(s): Navin K Kapur Added: 2 months ago
ACC.26 – Dr Navin Kapur (Tufts Medicine, Boston, MA, US) joins us to discuss findings from the STEMI-Door To Unload (DTU) randomised clinical trial, examining whether primary left ventricular unloading with the Impella CP® device prior to reperfusion can reduce infarct size and heart failure-related outcomes in patients presenting with anterior ST-elevation myocardial infarction.This prospective,… View more

Intervention

Heart Failure
Ventricular Assist Device - ABIOMED, Inc.
Abiomed: Manufacturer of Impella®Percutaneous Ventricular Assist DeviceAbiomed, founded in 1981, is a global pioneer in healthcare technology, with a mission to recover hearts and save lives.From the World’s first total replacement heart pump to the World’s smallest heart pump, Abiomed has developed a family of ventricular assist devices (VAD), namely the Impella® platform of percutaneous VADs… View more